資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/29947
|
| 題名: | Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds |
| 作者: | Lin, CW;Tsai, FJ;Tsai, CH;Lai, CC;Wan, L;Ho, TY;Hsieh, CC;Chao, PDL |
| 貢獻者: | 附設醫院基因醫學部;China Med Univ Hosp, Dept Med Genet & Med Res, Taichung 404, Taiwan;China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung 404, Taiwan;China Med Univ Hosp, Dept Lab Med, Clin Virol Lab, Taichung 404, Taiwan;China Med Univ, Inst Chinese Med Sci, Taichung 404, Taiwan;China Med Univ, Inst Integrat Chinese & Western Med, Taichung 404, Taiwan;China Med Univ, Dept Pharm, Taichung 404, Taiwan |
| 日期: | 2005 |
| 上傳時間: | 2010-09-24 14:46:17 (UTC+8) |
| 出版者: | ELSEVIER SCIENCE BV |
| 摘要: | The choice of emergency treatment of ruptured hepatocellular carcinoma (HCC) remains controversial. This study analyzed the prognostic factors for ruptured HCC seen in an ED. Patients were retrospectively classified into survival and mortality groups. Fifty-five patients were enrolled into this study, and the hospital mortality rate was 38.2%. There were no associations of clinical presentation, tumor characteristics, and emergency treatment method with patients' prognoses. Significantly higher mortality rate was noted in patients with poor liver function. The time between admission and emergency chemoembolization was significantly shorter in the mortality group than in the survival group (mean, 255 vs 394 minutes). The 1-month survival rate was 69% in patients who received conservative treatment and 59% in patients who underwent emergency chemoembolization. Routine emergency chemoembolization did not improve outcome and was associated with higher mortality and complication rates, especially in patients with poor liver function. Conservative therapy may be a preferable option for patients with ruptured HCC if they have baseline poor liver function. (c) 2005 Elsevier Inc. All rights reserved. |
| 關聯: | ANTIVIRAL RESEARCH 68(1):36-42 |
| 顯示於類別: | [台中附設醫院] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
